LifeStance (LFST) director awarded 74,766 RSUs at $0.00

LifeStance Health Group (LFST) reported an insider equity award.

Accepted by SEC EDGAR 10/28/2025 - 08:37 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

LifeStance Health Group (LFST) reported an insider equity award. A director acquired 74,766 shares of common stock on 08/20/2025 at $0.00, as shown on a Form 4.

The filing states these are restricted stock units (RSUs), with each RSU representing a right to receive one share of common stock. Following the reported transaction, the director beneficially owned 74,766 shares, held directly.

Insider Trade Summary

Grant/Award: 74,766 shares

Grant/Award 1 txn

Insider Personette Sarah

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	74,766	$0.00	$0.00

Holdings After Transaction: Common Stock — 74,766 shares (Direct)

Footnotes (1)

1. F1. Includes 74,766 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LifeStance (LFST) report in this Form 4?

A director acquired 74,766 shares via an equity award on 08/20/2025 at $0.00.

How many RSUs were granted to the LifeStance director?

The filing notes 74,766 RSUs, each representing a right to one share of common stock.

What was the price per share for the reported LifeStance transaction?

The reported price was $0.00 per share.

How many LifeStance shares are beneficially owned after the transaction?

Beneficial ownership following the transaction was 74,766 shares.

What is the ownership form for the LifeStance shares?

The filing lists ownership as Direct.

What is the role of the reporting person at LifeStance (LFST)?

The reporting person is a Director.

What does each RSU represent in this LifeStance filing?

Each RSU represents a contingent right to receive one share of LifeStance common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Personette Sarah

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		74,766(1)	A	$0.00	74,766	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 74,766 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

	By: /s/ Ryan Pardo, Attorney-in-Fact	10/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.